Association of Prolonged Disease Duration and TG/HDL-C Ratio in Accelerating Atherosclerosis in Patients with Takayasu's Arteritis

Background and aim: Takayasu's arteritis (TA) is a chronic inflammation that frequently involves the aorta and its major branches. It has been known that atherosclerosis can occur in some TA patients. Objectives: This study aimed to identify the risk factors associated with the development of atherosclerosis in TA. Methods: This retrospective study enrolled a total of 101 TA patients. All patients were divided into two groups according to the absence or presence of atherosclerosis. Baseline demographic features and clinical characteristics were compared between two groups. A logistic model was applied to determine the risk factors associated with the development of atherosclerosis. Results: Our data suggested that the disease duration of patients in the atherosclerosis group was significantly longer than that of patients in the non-atherosclerosis group [96(18.00, 180.00) versus 48.00(12.00, 111.00) months] (P = .015). In addition, the average age of patients with atherosclerosis was significantly older compared to patients without atherosclerosis [44.00(38.00, 48.00)versus 28.50(24.00,37.00)years] (P < .001). Logistic regression analysis showed that the risk of developing atherosclerosis increased by 9.2% per 1 year increase in the disease duration (P = .005, OR 1.092, 95%CI: 1.027-1.162). Patients with TG/HDL-C ratio more than 0.8875 were associated with a 5.861fold increase of risk developing atherosclerosis (P < .001, OR 5.861, 95%CI: 2.299-14.939). Conclusion: Our study indicated that prolonged disease duration and elevated TG/HDL-C ratio are associated with the development of atherosclerosis in TA patients.

[1]  P. Nienhuis,et al.  A Review on the Value of Imaging in Differentiating between Large Vessel Vasculitis and Atherosclerosis , 2021, Journal of personalized medicine.

[2]  Qingbo Xu,et al.  Trajectories of Age-Related Arterial Stiffness in Chinese Men and Women. , 2020, Journal of the American College of Cardiology.

[3]  Rachel M. Kenney,et al.  Sex differences in mechanisms of arterial stiffness , 2019, British journal of pharmacology.

[4]  Shouling Wu,et al.  Higher triglyceride to high‐density lipoprotein cholesterol ratio increases cardiovascular risk: 10‐year prospective study in a cohort of Chinese adults , 2019, Journal of diabetes investigation.

[5]  C. Turesson,et al.  2018 Update of the EULAR recommendations for the management of large vessel vasculitis , 2019, Annals of the rheumatic diseases.

[6]  M. Hemmati,et al.  Cardiovascular Risk Factors and Atherogenic Indices in an Iranian Population: Birjand East of Iran , 2018, Clinical Medicine Insights. Cardiology.

[7]  P. Sfikakis,et al.  Accelerated atheromatosis and arteriosclerosis in primary systemic vasculitides: current evidence and future perspectives , 2018, Current opinion in rheumatology.

[8]  Y. Yılmaz,et al.  Is triglyceride/HDL ratio a reliable screening test for assessment of atherosclerotic risk in patients with chronic inflammatory disease? , 2016, Northern clinics of Istanbul.

[9]  S. Heymans,et al.  Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis. , 2015, International journal of cardiology.

[10]  Dinesh Kumar,et al.  NMR-Based Serum Metabolomics Discriminates Takayasu Arteritis from Healthy Individuals: A Proof-of-Principle Study. , 2015, Journal of proteome research.

[11]  Yucheng Chen,et al.  The Association between Triglyceride/High-Density Lipoprotein Cholesterol Ratio and All-Cause Mortality in Acute Coronary Syndrome after Coronary Revascularization , 2015, PloS one.

[12]  J. Francis,et al.  Gender specific patterns of age-related decline in aortic stiffness: a cardiovascular magnetic resonance study including normal ranges , 2015, Journal of Cardiovascular Magnetic Resonance.

[13]  J. Grau,et al.  Evaluation of Aortic Inflammation Using Computed Tomographic Angiography: Vasculitis, Atherosclerosis, or Both , 2015, Journal of the American Geriatrics Society.

[14]  A. Dang,et al.  Association of abnormal lipid spectrum with the disease activity of Takayasu arteritis , 2015, Clinical Rheumatology.

[15]  H. Direskeneli,et al.  Impaired endothelial function in patients with Takayasu’s arteritis , 2014, Acta cardiologica.

[16]  Rajiva Gupta,et al.  Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010). , 2013, Rheumatology.

[17]  S. Yurdakul,et al.  Aortic and coronary calcifications in Takayasu arteritis. , 2013, Seminars in arthritis and rheumatism.

[18]  S. Gabriel,et al.  Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE , 2011, Nature Reviews Rheumatology.

[19]  D. Symmons,et al.  Are Lipid Ratios Less Susceptible to Change With Systemic Inflammation Than Individual Lipid Components in Patients With Rheumatoid Arthritis? , 2011, Angiology.

[20]  B. Dijkmans,et al.  The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better , 2010, International journal of clinical practice.

[21]  S. Juo,et al.  The risk of the metabolic syndrome on carotid thickness and stiffness: sex and age specific effects. , 2010, Atherosclerosis.

[22]  D. Symmons,et al.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis , 2009, Annals of the rheumatic diseases.

[23]  R. Pereira,et al.  High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis , 2009, Clinical Rheumatology.

[24]  S. Heo,et al.  Takayasu’s disease presenting with atherothrombotic ischaemic stroke , 2008, Neurological Sciences.

[25]  W. Mack,et al.  Carotid artery intima-media thickness after raloxifene treatment. , 2007, Journal of women's health.

[26]  F. Dockery,et al.  Takayasu's arteritis: a cause of prolonged arterial stiffness. , 2006, Rheumatology.

[27]  N. Seyahi,et al.  Atherosclerosis in Takayasu arteritis , 2006, Annals of the rheumatic diseases.

[28]  H. Hashimoto,et al.  Menopause is an independent factor augmenting the age-related increase in arterial stiffness in the early postmenopausal phase. , 2006, Atherosclerosis.

[29]  K. G. Rajesh,et al.  Antioxidant MCI-186 inhibits mitochondrial permeability transition pore and upregulates Bcl-2 expression. , 2003, American journal of physiology. Heart and circulatory physiology.

[30]  T. Kakuta,et al.  Inflammation and Atherosclerosis: Atherosclerotic Lesions in Takayasu Arteritis , 2000, Annals of the New York Academy of Sciences.

[31]  F. Numano,et al.  Angiographic findings of Takayasu arteritis: new classification. , 1996, International journal of cardiology.

[32]  Guy Hoffman,et al.  Takayasu Arteritis , 1994, Annals of Internal Medicine.

[33]  G. Hunder,et al.  The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. , 2010, Arthritis and rheumatism.

[34]  M. Srichai,et al.  Takayasu's Arteritis , 2012 .